nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—Cytochrome P450 3A4 Inhibitors—Pazopanib—kidney cancer	0.285	0.5	CiPCiCtD
Boceprevir—Cytochrome P450 3A4 Inhibitors—Everolimus—kidney cancer	0.285	0.5	CiPCiCtD
Boceprevir—ABCB1—kidney cancer	0.0748	1	CbGaD
Boceprevir—CYP3A5—Temsirolimus—kidney cancer	0.0235	0.135	CbGbCtD
Boceprevir—ABCB1—Temsirolimus—kidney cancer	0.0153	0.0876	CbGbCtD
Boceprevir—CYP3A4—Everolimus—kidney cancer	0.0136	0.0777	CbGbCtD
Boceprevir—CYP3A4—Temsirolimus—kidney cancer	0.00918	0.0525	CbGbCtD
Boceprevir—CYP3A5—Erlotinib—kidney cancer	0.00882	0.0505	CbGbCtD
Boceprevir—CYP3A5—Paclitaxel—kidney cancer	0.00808	0.0462	CbGbCtD
Boceprevir—ABCB1—Pazopanib—kidney cancer	0.00805	0.046	CbGbCtD
Boceprevir—ABCB1—Dactinomycin—kidney cancer	0.00736	0.0421	CbGbCtD
Boceprevir—CYP3A5—Sorafenib—kidney cancer	0.00718	0.041	CbGbCtD
Boceprevir—CYP3A5—Vincristine—kidney cancer	0.00697	0.0398	CbGbCtD
Boceprevir—ABCB1—Gemcitabine—kidney cancer	0.00582	0.0333	CbGbCtD
Boceprevir—CYP3A5—Sunitinib—kidney cancer	0.00581	0.0333	CbGbCtD
Boceprevir—ABCB1—Erlotinib—kidney cancer	0.00574	0.0329	CbGbCtD
Boceprevir—ABCB1—Paclitaxel—kidney cancer	0.00526	0.0301	CbGbCtD
Boceprevir—CYP3A4—Pazopanib—kidney cancer	0.00482	0.0276	CbGbCtD
Boceprevir—ABCB1—Sorafenib—kidney cancer	0.00467	0.0267	CbGbCtD
Boceprevir—ABCB1—Vinblastine—kidney cancer	0.00461	0.0264	CbGbCtD
Boceprevir—ABCB1—Vincristine—kidney cancer	0.00453	0.0259	CbGbCtD
Boceprevir—ABCB1—Sunitinib—kidney cancer	0.00378	0.0216	CbGbCtD
Boceprevir—CYP3A4—Erlotinib—kidney cancer	0.00344	0.0197	CbGbCtD
Boceprevir—CYP3A4—Paclitaxel—kidney cancer	0.00315	0.018	CbGbCtD
Boceprevir—ABCB1—Doxorubicin—kidney cancer	0.00283	0.0162	CbGbCtD
Boceprevir—CYP3A4—Sorafenib—kidney cancer	0.0028	0.016	CbGbCtD
Boceprevir—CYP3A4—Vinblastine—kidney cancer	0.00276	0.0158	CbGbCtD
Boceprevir—CYP3A4—Vincristine—kidney cancer	0.00272	0.0155	CbGbCtD
Boceprevir—CYP3A4—Sunitinib—kidney cancer	0.00227	0.013	CbGbCtD
Boceprevir—CTSV—nephron tubule—kidney cancer	0.00179	0.0687	CbGeAlD
Boceprevir—CYP3A4—Doxorubicin—kidney cancer	0.0017	0.00971	CbGbCtD
Boceprevir—CTSV—renal system—kidney cancer	0.00162	0.0625	CbGeAlD
Boceprevir—CTSV—kidney—kidney cancer	0.00157	0.0604	CbGeAlD
Boceprevir—CTSV—cortex of kidney—kidney cancer	0.00153	0.0588	CbGeAlD
Boceprevir—CTSL—nephron tubule—kidney cancer	0.00146	0.0561	CbGeAlD
Boceprevir—CTSV—gonad—kidney cancer	0.00146	0.056	CbGeAlD
Boceprevir—CTSL—renal system—kidney cancer	0.00133	0.051	CbGeAlD
Boceprevir—CTSL—kidney—kidney cancer	0.00128	0.0493	CbGeAlD
Boceprevir—CTSL—cortex of kidney—kidney cancer	0.00125	0.048	CbGeAlD
Boceprevir—CTSL—gonad—kidney cancer	0.00119	0.0458	CbGeAlD
Boceprevir—CTSL—cardiac atrium—kidney cancer	0.00119	0.0457	CbGeAlD
Boceprevir—CTSK—renal system—kidney cancer	0.000999	0.0384	CbGeAlD
Boceprevir—CTSK—kidney—kidney cancer	0.000966	0.0372	CbGeAlD
Boceprevir—CTSK—gonad—kidney cancer	0.000896	0.0345	CbGeAlD
Boceprevir—CTSK—cardiac atrium—kidney cancer	0.000895	0.0344	CbGeAlD
Boceprevir—CYP3A4—urine—kidney cancer	0.000892	0.0343	CbGeAlD
Boceprevir—CTSS—renal system—kidney cancer	0.000876	0.0337	CbGeAlD
Boceprevir—CTSS—kidney—kidney cancer	0.000846	0.0326	CbGeAlD
Boceprevir—CTSS—cortex of kidney—kidney cancer	0.000824	0.0317	CbGeAlD
Boceprevir—CTSS—gonad—kidney cancer	0.000785	0.0302	CbGeAlD
Boceprevir—Telaprevir—ABCB1—kidney cancer	0.000501	1	CrCbGaD
Boceprevir—CYP3A5—nephron tubule—kidney cancer	0.00032	0.0123	CbGeAlD
Boceprevir—CYP3A5—renal system—kidney cancer	0.000291	0.0112	CbGeAlD
Boceprevir—CYP3A5—kidney—kidney cancer	0.000281	0.0108	CbGeAlD
Boceprevir—CYP3A5—cortex of kidney—kidney cancer	0.000274	0.0105	CbGeAlD
Boceprevir—CYP3A4—renal system—kidney cancer	0.000218	0.0084	CbGeAlD
Boceprevir—CYP3A4—kidney—kidney cancer	0.000211	0.00812	CbGeAlD
Boceprevir—ABCB1—nephron tubule—kidney cancer	0.00017	0.00654	CbGeAlD
Boceprevir—ABCB1—renal system—kidney cancer	0.000154	0.00594	CbGeAlD
Boceprevir—ABCB1—kidney—kidney cancer	0.000149	0.00575	CbGeAlD
Boceprevir—ABCB1—cortex of kidney—kidney cancer	0.000145	0.0056	CbGeAlD
Boceprevir—ABCB1—gonad—kidney cancer	0.000139	0.00533	CbGeAlD
Boceprevir—Dizziness—Sorafenib—kidney cancer	2.45e-05	0.000243	CcSEcCtD
Boceprevir—Constipation—Gemcitabine—kidney cancer	2.45e-05	0.000243	CcSEcCtD
Boceprevir—Pain—Gemcitabine—kidney cancer	2.45e-05	0.000243	CcSEcCtD
Boceprevir—Nausea—Erlotinib—kidney cancer	2.45e-05	0.000243	CcSEcCtD
Boceprevir—Alopecia—Capecitabine—kidney cancer	2.44e-05	0.000243	CcSEcCtD
Boceprevir—Dry mouth—Paclitaxel—kidney cancer	2.44e-05	0.000242	CcSEcCtD
Boceprevir—Mood swings—Doxorubicin—kidney cancer	2.44e-05	0.000242	CcSEcCtD
Boceprevir—Diarrhoea—Sunitinib—kidney cancer	2.44e-05	0.000242	CcSEcCtD
Boceprevir—Mental disorder—Capecitabine—kidney cancer	2.42e-05	0.000241	CcSEcCtD
Boceprevir—Asthenia—Dactinomycin—kidney cancer	2.42e-05	0.00024	CcSEcCtD
Boceprevir—Confusional state—Paclitaxel—kidney cancer	2.41e-05	0.00024	CcSEcCtD
Boceprevir—Malnutrition—Capecitabine—kidney cancer	2.41e-05	0.000239	CcSEcCtD
Boceprevir—Erythema—Capecitabine—kidney cancer	2.41e-05	0.000239	CcSEcCtD
Boceprevir—Dehydration—Doxorubicin—kidney cancer	2.4e-05	0.000238	CcSEcCtD
Boceprevir—Abdominal pain—Vincristine—kidney cancer	2.38e-05	0.000237	CcSEcCtD
Boceprevir—Body temperature increased—Vincristine—kidney cancer	2.38e-05	0.000237	CcSEcCtD
Boceprevir—Infection—Paclitaxel—kidney cancer	2.38e-05	0.000236	CcSEcCtD
Boceprevir—Flatulence—Capecitabine—kidney cancer	2.37e-05	0.000235	CcSEcCtD
Boceprevir—Dry skin—Doxorubicin—kidney cancer	2.36e-05	0.000234	CcSEcCtD
Boceprevir—Dysgeusia—Capecitabine—kidney cancer	2.36e-05	0.000234	CcSEcCtD
Boceprevir—Dizziness—Sunitinib—kidney cancer	2.36e-05	0.000234	CcSEcCtD
Boceprevir—Feeling abnormal—Gemcitabine—kidney cancer	2.36e-05	0.000234	CcSEcCtD
Boceprevir—Shock—Paclitaxel—kidney cancer	2.36e-05	0.000234	CcSEcCtD
Boceprevir—Vomiting—Sorafenib—kidney cancer	2.36e-05	0.000234	CcSEcCtD
Boceprevir—Abdominal pain upper—Doxorubicin—kidney cancer	2.35e-05	0.000234	CcSEcCtD
Boceprevir—Nervous system disorder—Paclitaxel—kidney cancer	2.35e-05	0.000233	CcSEcCtD
Boceprevir—Hypokalaemia—Doxorubicin—kidney cancer	2.35e-05	0.000233	CcSEcCtD
Boceprevir—Thrombocytopenia—Paclitaxel—kidney cancer	2.35e-05	0.000233	CcSEcCtD
Boceprevir—Tachycardia—Paclitaxel—kidney cancer	2.34e-05	0.000232	CcSEcCtD
Boceprevir—Rash—Sorafenib—kidney cancer	2.34e-05	0.000232	CcSEcCtD
Boceprevir—Dermatitis—Sorafenib—kidney cancer	2.33e-05	0.000232	CcSEcCtD
Boceprevir—Back pain—Capecitabine—kidney cancer	2.33e-05	0.000231	CcSEcCtD
Boceprevir—Breast disorder—Doxorubicin—kidney cancer	2.33e-05	0.000231	CcSEcCtD
Boceprevir—Skin disorder—Paclitaxel—kidney cancer	2.33e-05	0.000231	CcSEcCtD
Boceprevir—Headache—Sorafenib—kidney cancer	2.32e-05	0.00023	CcSEcCtD
Boceprevir—Muscle spasms—Capecitabine—kidney cancer	2.32e-05	0.00023	CcSEcCtD
Boceprevir—Hyperhidrosis—Paclitaxel—kidney cancer	2.32e-05	0.00023	CcSEcCtD
Boceprevir—Diarrhoea—Dactinomycin—kidney cancer	2.31e-05	0.000229	CcSEcCtD
Boceprevir—Nasopharyngitis—Doxorubicin—kidney cancer	2.31e-05	0.000229	CcSEcCtD
Boceprevir—Gastritis—Doxorubicin—kidney cancer	2.28e-05	0.000226	CcSEcCtD
Boceprevir—Muscular weakness—Doxorubicin—kidney cancer	2.27e-05	0.000226	CcSEcCtD
Boceprevir—Vision blurred—Capecitabine—kidney cancer	2.27e-05	0.000225	CcSEcCtD
Boceprevir—Vomiting—Sunitinib—kidney cancer	2.27e-05	0.000225	CcSEcCtD
Boceprevir—Body temperature increased—Gemcitabine—kidney cancer	2.26e-05	0.000224	CcSEcCtD
Boceprevir—Rash—Sunitinib—kidney cancer	2.25e-05	0.000223	CcSEcCtD
Boceprevir—Dermatitis—Sunitinib—kidney cancer	2.25e-05	0.000223	CcSEcCtD
Boceprevir—Abdominal distension—Doxorubicin—kidney cancer	2.24e-05	0.000223	CcSEcCtD
Boceprevir—Hypotension—Paclitaxel—kidney cancer	2.24e-05	0.000222	CcSEcCtD
Boceprevir—Ill-defined disorder—Capecitabine—kidney cancer	2.23e-05	0.000222	CcSEcCtD
Boceprevir—Headache—Sunitinib—kidney cancer	2.23e-05	0.000222	CcSEcCtD
Boceprevir—Influenza—Doxorubicin—kidney cancer	2.23e-05	0.000221	CcSEcCtD
Boceprevir—Dysphagia—Doxorubicin—kidney cancer	2.23e-05	0.000221	CcSEcCtD
Boceprevir—Anaemia—Capecitabine—kidney cancer	2.23e-05	0.000221	CcSEcCtD
Boceprevir—Hypersensitivity—Vincristine—kidney cancer	2.22e-05	0.00022	CcSEcCtD
Boceprevir—Eosinophilia—Doxorubicin—kidney cancer	2.21e-05	0.000219	CcSEcCtD
Boceprevir—Nausea—Sorafenib—kidney cancer	2.2e-05	0.000218	CcSEcCtD
Boceprevir—Pancreatitis—Doxorubicin—kidney cancer	2.18e-05	0.000217	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Paclitaxel—kidney cancer	2.18e-05	0.000217	CcSEcCtD
Boceprevir—Malaise—Capecitabine—kidney cancer	2.17e-05	0.000216	CcSEcCtD
Boceprevir—Insomnia—Paclitaxel—kidney cancer	2.17e-05	0.000215	CcSEcCtD
Boceprevir—Vertigo—Capecitabine—kidney cancer	2.16e-05	0.000215	CcSEcCtD
Boceprevir—Asthenia—Vincristine—kidney cancer	2.16e-05	0.000215	CcSEcCtD
Boceprevir—Syncope—Capecitabine—kidney cancer	2.16e-05	0.000214	CcSEcCtD
Boceprevir—Leukopenia—Capecitabine—kidney cancer	2.16e-05	0.000214	CcSEcCtD
Boceprevir—Paraesthesia—Paclitaxel—kidney cancer	2.15e-05	0.000213	CcSEcCtD
Boceprevir—Vomiting—Dactinomycin—kidney cancer	2.15e-05	0.000213	CcSEcCtD
Boceprevir—Bronchitis—Doxorubicin—kidney cancer	2.14e-05	0.000213	CcSEcCtD
Boceprevir—Dyspnoea—Paclitaxel—kidney cancer	2.14e-05	0.000212	CcSEcCtD
Boceprevir—Palpitations—Capecitabine—kidney cancer	2.13e-05	0.000211	CcSEcCtD
Boceprevir—Rash—Dactinomycin—kidney cancer	2.13e-05	0.000211	CcSEcCtD
Boceprevir—Nausea—Sunitinib—kidney cancer	2.12e-05	0.00021	CcSEcCtD
Boceprevir—Loss of consciousness—Capecitabine—kidney cancer	2.12e-05	0.00021	CcSEcCtD
Boceprevir—Pancytopenia—Doxorubicin—kidney cancer	2.12e-05	0.00021	CcSEcCtD
Boceprevir—Dyspepsia—Paclitaxel—kidney cancer	2.11e-05	0.000209	CcSEcCtD
Boceprevir—Cough—Capecitabine—kidney cancer	2.1e-05	0.000209	CcSEcCtD
Boceprevir—Dysuria—Doxorubicin—kidney cancer	2.08e-05	0.000207	CcSEcCtD
Boceprevir—Neutropenia—Doxorubicin—kidney cancer	2.08e-05	0.000207	CcSEcCtD
Boceprevir—Decreased appetite—Paclitaxel—kidney cancer	2.08e-05	0.000207	CcSEcCtD
Boceprevir—Hypertension—Capecitabine—kidney cancer	2.08e-05	0.000206	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Paclitaxel—kidney cancer	2.07e-05	0.000205	CcSEcCtD
Boceprevir—Fatigue—Paclitaxel—kidney cancer	2.06e-05	0.000205	CcSEcCtD
Boceprevir—Diarrhoea—Vincristine—kidney cancer	2.06e-05	0.000205	CcSEcCtD
Boceprevir—Pollakiuria—Doxorubicin—kidney cancer	2.06e-05	0.000204	CcSEcCtD
Boceprevir—Asthenia—Gemcitabine—kidney cancer	2.05e-05	0.000204	CcSEcCtD
Boceprevir—Chest pain—Capecitabine—kidney cancer	2.05e-05	0.000203	CcSEcCtD
Boceprevir—Myalgia—Capecitabine—kidney cancer	2.05e-05	0.000203	CcSEcCtD
Boceprevir—Arthralgia—Capecitabine—kidney cancer	2.05e-05	0.000203	CcSEcCtD
Boceprevir—Pain—Paclitaxel—kidney cancer	2.05e-05	0.000203	CcSEcCtD
Boceprevir—Constipation—Paclitaxel—kidney cancer	2.05e-05	0.000203	CcSEcCtD
Boceprevir—Anxiety—Capecitabine—kidney cancer	2.04e-05	0.000203	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	2.04e-05	0.000202	CcSEcCtD
Boceprevir—Photosensitivity reaction—Doxorubicin—kidney cancer	2.03e-05	0.000202	CcSEcCtD
Boceprevir—Discomfort—Capecitabine—kidney cancer	2.03e-05	0.000201	CcSEcCtD
Boceprevir—Pruritus—Gemcitabine—kidney cancer	2.02e-05	0.000201	CcSEcCtD
Boceprevir—Weight decreased—Doxorubicin—kidney cancer	2.02e-05	0.0002	CcSEcCtD
Boceprevir—Hyperglycaemia—Doxorubicin—kidney cancer	2.01e-05	0.000199	CcSEcCtD
Boceprevir—Dry mouth—Capecitabine—kidney cancer	2.01e-05	0.000199	CcSEcCtD
Boceprevir—Nausea—Dactinomycin—kidney cancer	2e-05	0.000199	CcSEcCtD
Boceprevir—Pneumonia—Doxorubicin—kidney cancer	2e-05	0.000198	CcSEcCtD
Boceprevir—Dizziness—Vincristine—kidney cancer	1.99e-05	0.000198	CcSEcCtD
Boceprevir—Infestation NOS—Doxorubicin—kidney cancer	1.99e-05	0.000197	CcSEcCtD
Boceprevir—Infestation—Doxorubicin—kidney cancer	1.99e-05	0.000197	CcSEcCtD
Boceprevir—Confusional state—Capecitabine—kidney cancer	1.98e-05	0.000197	CcSEcCtD
Boceprevir—Feeling abnormal—Paclitaxel—kidney cancer	1.97e-05	0.000196	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	1.97e-05	0.000195	CcSEcCtD
Boceprevir—Gastrointestinal pain—Paclitaxel—kidney cancer	1.96e-05	0.000194	CcSEcCtD
Boceprevir—Diarrhoea—Gemcitabine—kidney cancer	1.96e-05	0.000194	CcSEcCtD
Boceprevir—Infection—Capecitabine—kidney cancer	1.95e-05	0.000194	CcSEcCtD
Boceprevir—Neuropathy peripheral—Doxorubicin—kidney cancer	1.95e-05	0.000193	CcSEcCtD
Boceprevir—Stomatitis—Doxorubicin—kidney cancer	1.94e-05	0.000192	CcSEcCtD
Boceprevir—Shock—Capecitabine—kidney cancer	1.93e-05	0.000192	CcSEcCtD
Boceprevir—Urinary tract infection—Doxorubicin—kidney cancer	1.93e-05	0.000192	CcSEcCtD
Boceprevir—Conjunctivitis—Doxorubicin—kidney cancer	1.93e-05	0.000192	CcSEcCtD
Boceprevir—Nervous system disorder—Capecitabine—kidney cancer	1.93e-05	0.000191	CcSEcCtD
Boceprevir—Thrombocytopenia—Capecitabine—kidney cancer	1.92e-05	0.000191	CcSEcCtD
Boceprevir—Tachycardia—Capecitabine—kidney cancer	1.92e-05	0.00019	CcSEcCtD
Boceprevir—Vomiting—Vincristine—kidney cancer	1.92e-05	0.00019	CcSEcCtD
Boceprevir—Skin disorder—Capecitabine—kidney cancer	1.91e-05	0.000189	CcSEcCtD
Boceprevir—Urticaria—Paclitaxel—kidney cancer	1.9e-05	0.000189	CcSEcCtD
Boceprevir—Rash—Vincristine—kidney cancer	1.9e-05	0.000189	CcSEcCtD
Boceprevir—Hyperhidrosis—Capecitabine—kidney cancer	1.9e-05	0.000189	CcSEcCtD
Boceprevir—Dermatitis—Vincristine—kidney cancer	1.9e-05	0.000189	CcSEcCtD
Boceprevir—Abdominal pain—Paclitaxel—kidney cancer	1.89e-05	0.000188	CcSEcCtD
Boceprevir—Body temperature increased—Paclitaxel—kidney cancer	1.89e-05	0.000188	CcSEcCtD
Boceprevir—Headache—Vincristine—kidney cancer	1.89e-05	0.000187	CcSEcCtD
Boceprevir—Hepatobiliary disease—Doxorubicin—kidney cancer	1.88e-05	0.000186	CcSEcCtD
Boceprevir—Epistaxis—Doxorubicin—kidney cancer	1.87e-05	0.000186	CcSEcCtD
Boceprevir—Sinusitis—Doxorubicin—kidney cancer	1.86e-05	0.000185	CcSEcCtD
Boceprevir—Agranulocytosis—Doxorubicin—kidney cancer	1.85e-05	0.000184	CcSEcCtD
Boceprevir—Hypotension—Capecitabine—kidney cancer	1.84e-05	0.000182	CcSEcCtD
Boceprevir—Vomiting—Gemcitabine—kidney cancer	1.82e-05	0.00018	CcSEcCtD
Boceprevir—Rash—Gemcitabine—kidney cancer	1.8e-05	0.000179	CcSEcCtD
Boceprevir—Dermatitis—Gemcitabine—kidney cancer	1.8e-05	0.000179	CcSEcCtD
Boceprevir—Headache—Gemcitabine—kidney cancer	1.79e-05	0.000178	CcSEcCtD
Boceprevir—Nausea—Vincristine—kidney cancer	1.79e-05	0.000178	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Capecitabine—kidney cancer	1.79e-05	0.000178	CcSEcCtD
Boceprevir—Rhinitis—Doxorubicin—kidney cancer	1.79e-05	0.000177	CcSEcCtD
Boceprevir—Insomnia—Capecitabine—kidney cancer	1.78e-05	0.000176	CcSEcCtD
Boceprevir—Hypoaesthesia—Doxorubicin—kidney cancer	1.77e-05	0.000176	CcSEcCtD
Boceprevir—Pharyngitis—Doxorubicin—kidney cancer	1.77e-05	0.000176	CcSEcCtD
Boceprevir—Paraesthesia—Capecitabine—kidney cancer	1.76e-05	0.000175	CcSEcCtD
Boceprevir—Hypersensitivity—Paclitaxel—kidney cancer	1.76e-05	0.000175	CcSEcCtD
Boceprevir—Urinary tract disorder—Doxorubicin—kidney cancer	1.76e-05	0.000175	CcSEcCtD
Boceprevir—Oedema peripheral—Doxorubicin—kidney cancer	1.76e-05	0.000174	CcSEcCtD
Boceprevir—Connective tissue disorder—Doxorubicin—kidney cancer	1.75e-05	0.000174	CcSEcCtD
Boceprevir—Dyspnoea—Capecitabine—kidney cancer	1.75e-05	0.000174	CcSEcCtD
Boceprevir—Urethral disorder—Doxorubicin—kidney cancer	1.75e-05	0.000173	CcSEcCtD
Boceprevir—Dyspepsia—Capecitabine—kidney cancer	1.73e-05	0.000172	CcSEcCtD
Boceprevir—Visual impairment—Doxorubicin—kidney cancer	1.72e-05	0.000171	CcSEcCtD
Boceprevir—Asthenia—Paclitaxel—kidney cancer	1.72e-05	0.000171	CcSEcCtD
Boceprevir—Decreased appetite—Capecitabine—kidney cancer	1.71e-05	0.00017	CcSEcCtD
Boceprevir—Nausea—Gemcitabine—kidney cancer	1.7e-05	0.000169	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Capecitabine—kidney cancer	1.7e-05	0.000168	CcSEcCtD
Boceprevir—Fatigue—Capecitabine—kidney cancer	1.69e-05	0.000168	CcSEcCtD
Boceprevir—Pruritus—Paclitaxel—kidney cancer	1.69e-05	0.000168	CcSEcCtD
Boceprevir—Erythema multiforme—Doxorubicin—kidney cancer	1.69e-05	0.000167	CcSEcCtD
Boceprevir—Pain—Capecitabine—kidney cancer	1.68e-05	0.000167	CcSEcCtD
Boceprevir—Constipation—Capecitabine—kidney cancer	1.68e-05	0.000167	CcSEcCtD
Boceprevir—Eye disorder—Doxorubicin—kidney cancer	1.67e-05	0.000165	CcSEcCtD
Boceprevir—Tinnitus—Doxorubicin—kidney cancer	1.66e-05	0.000165	CcSEcCtD
Boceprevir—Flushing—Doxorubicin—kidney cancer	1.66e-05	0.000164	CcSEcCtD
Boceprevir—Cardiac disorder—Doxorubicin—kidney cancer	1.66e-05	0.000164	CcSEcCtD
Boceprevir—Diarrhoea—Paclitaxel—kidney cancer	1.64e-05	0.000163	CcSEcCtD
Boceprevir—Feeling abnormal—Capecitabine—kidney cancer	1.62e-05	0.000161	CcSEcCtD
Boceprevir—Angiopathy—Doxorubicin—kidney cancer	1.62e-05	0.000161	CcSEcCtD
Boceprevir—Immune system disorder—Doxorubicin—kidney cancer	1.61e-05	0.00016	CcSEcCtD
Boceprevir—Gastrointestinal pain—Capecitabine—kidney cancer	1.61e-05	0.000159	CcSEcCtD
Boceprevir—Mediastinal disorder—Doxorubicin—kidney cancer	1.61e-05	0.000159	CcSEcCtD
Boceprevir—Chills—Doxorubicin—kidney cancer	1.6e-05	0.000159	CcSEcCtD
Boceprevir—Arrhythmia—Doxorubicin—kidney cancer	1.59e-05	0.000158	CcSEcCtD
Boceprevir—Dizziness—Paclitaxel—kidney cancer	1.58e-05	0.000157	CcSEcCtD
Boceprevir—Alopecia—Doxorubicin—kidney cancer	1.58e-05	0.000156	CcSEcCtD
Boceprevir—Mental disorder—Doxorubicin—kidney cancer	1.56e-05	0.000155	CcSEcCtD
Boceprevir—Urticaria—Capecitabine—kidney cancer	1.56e-05	0.000155	CcSEcCtD
Boceprevir—Abdominal pain—Capecitabine—kidney cancer	1.55e-05	0.000154	CcSEcCtD
Boceprevir—Body temperature increased—Capecitabine—kidney cancer	1.55e-05	0.000154	CcSEcCtD
Boceprevir—Malnutrition—Doxorubicin—kidney cancer	1.55e-05	0.000154	CcSEcCtD
Boceprevir—Erythema—Doxorubicin—kidney cancer	1.55e-05	0.000154	CcSEcCtD
Boceprevir—Flatulence—Doxorubicin—kidney cancer	1.53e-05	0.000152	CcSEcCtD
Boceprevir—Vomiting—Paclitaxel—kidney cancer	1.52e-05	0.000151	CcSEcCtD
Boceprevir—Dysgeusia—Doxorubicin—kidney cancer	1.52e-05	0.000151	CcSEcCtD
Boceprevir—Rash—Paclitaxel—kidney cancer	1.51e-05	0.00015	CcSEcCtD
Boceprevir—Dermatitis—Paclitaxel—kidney cancer	1.51e-05	0.00015	CcSEcCtD
Boceprevir—Back pain—Doxorubicin—kidney cancer	1.5e-05	0.000149	CcSEcCtD
Boceprevir—Headache—Paclitaxel—kidney cancer	1.5e-05	0.000149	CcSEcCtD
Boceprevir—Muscle spasms—Doxorubicin—kidney cancer	1.49e-05	0.000148	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	1.47e-05	0.000278	CbGpPWpGaD
Boceprevir—Vision blurred—Doxorubicin—kidney cancer	1.46e-05	0.000145	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CDKN1B—kidney cancer	1.46e-05	0.000275	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MAPK3—kidney cancer	1.45e-05	0.000274	CbGpPWpGaD
Boceprevir—Hypersensitivity—Capecitabine—kidney cancer	1.45e-05	0.000144	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—PIK3CA—kidney cancer	1.45e-05	0.000273	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PIK3CA—kidney cancer	1.45e-05	0.000273	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—JUN—kidney cancer	1.45e-05	0.000273	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Doxorubicin—kidney cancer	1.44e-05	0.000143	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CTNNB1—kidney cancer	1.44e-05	0.000271	CbGpPWpGaD
Boceprevir—Anaemia—Doxorubicin—kidney cancer	1.43e-05	0.000142	CcSEcCtD
Boceprevir—Agitation—Doxorubicin—kidney cancer	1.43e-05	0.000142	CcSEcCtD
Boceprevir—Nausea—Paclitaxel—kidney cancer	1.42e-05	0.000141	CcSEcCtD
Boceprevir—CTSV—Immune System—RAF1—kidney cancer	1.42e-05	0.000267	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RAF1—kidney cancer	1.42e-05	0.000267	CbGpPWpGaD
Boceprevir—Asthenia—Capecitabine—kidney cancer	1.41e-05	0.00014	CcSEcCtD
Boceprevir—CTSV—Immune System—RELA—kidney cancer	1.41e-05	0.000266	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RELA—kidney cancer	1.41e-05	0.000266	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ERBB2—kidney cancer	1.4e-05	0.000264	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ERBB2—kidney cancer	1.4e-05	0.000264	CbGpPWpGaD
Boceprevir—Malaise—Doxorubicin—kidney cancer	1.4e-05	0.000139	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—PTEN—kidney cancer	1.4e-05	0.000264	CbGpPWpGaD
Boceprevir—Vertigo—Doxorubicin—kidney cancer	1.39e-05	0.000138	CcSEcCtD
Boceprevir—CTSS—Immune System—TSC2—kidney cancer	1.39e-05	0.000263	CbGpPWpGaD
Boceprevir—Syncope—Doxorubicin—kidney cancer	1.39e-05	0.000138	CcSEcCtD
Boceprevir—Pruritus—Capecitabine—kidney cancer	1.39e-05	0.000138	CcSEcCtD
Boceprevir—Leukopenia—Doxorubicin—kidney cancer	1.39e-05	0.000138	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—PIK3CA—kidney cancer	1.39e-05	0.000262	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PIK3CA—kidney cancer	1.39e-05	0.000262	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MTOR—kidney cancer	1.38e-05	0.000261	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MTOR—kidney cancer	1.38e-05	0.000261	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MAPK1—kidney cancer	1.38e-05	0.000261	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD4—kidney cancer	1.38e-05	0.00026	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD4—kidney cancer	1.38e-05	0.00026	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	1.38e-05	0.00026	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	1.38e-05	0.00026	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CDH1—kidney cancer	1.38e-05	0.000259	CbGpPWpGaD
Boceprevir—Palpitations—Doxorubicin—kidney cancer	1.37e-05	0.000136	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—ACY1—kidney cancer	1.36e-05	0.000258	CbGpPWpGaD
Boceprevir—Loss of consciousness—Doxorubicin—kidney cancer	1.36e-05	0.000135	CcSEcCtD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.36e-05	0.000256	CbGpPWpGaD
Boceprevir—Cough—Doxorubicin—kidney cancer	1.35e-05	0.000134	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	1.35e-05	0.000255	CbGpPWpGaD
Boceprevir—Diarrhoea—Capecitabine—kidney cancer	1.34e-05	0.000133	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—PTEN—kidney cancer	1.34e-05	0.000253	CbGpPWpGaD
Boceprevir—Hypertension—Doxorubicin—kidney cancer	1.34e-05	0.000133	CcSEcCtD
Boceprevir—Myalgia—Doxorubicin—kidney cancer	1.32e-05	0.000131	CcSEcCtD
Boceprevir—Arthralgia—Doxorubicin—kidney cancer	1.32e-05	0.000131	CcSEcCtD
Boceprevir—Chest pain—Doxorubicin—kidney cancer	1.32e-05	0.000131	CcSEcCtD
Boceprevir—Anxiety—Doxorubicin—kidney cancer	1.32e-05	0.000131	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.31e-05	0.00013	CcSEcCtD
Boceprevir—Discomfort—Doxorubicin—kidney cancer	1.31e-05	0.00013	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—KRAS—kidney cancer	1.3e-05	0.000246	CbGpPWpGaD
Boceprevir—Dizziness—Capecitabine—kidney cancer	1.3e-05	0.000129	CcSEcCtD
Boceprevir—CTSL—Immune System—CDKN1B—kidney cancer	1.3e-05	0.000245	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDKN1B—kidney cancer	1.3e-05	0.000245	CbGpPWpGaD
Boceprevir—Dry mouth—Doxorubicin—kidney cancer	1.29e-05	0.000128	CcSEcCtD
Boceprevir—Confusional state—Doxorubicin—kidney cancer	1.28e-05	0.000127	CcSEcCtD
Boceprevir—CTSL—Immune System—IL2—kidney cancer	1.27e-05	0.000239	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL2—kidney cancer	1.27e-05	0.000239	CbGpPWpGaD
Boceprevir—Infection—Doxorubicin—kidney cancer	1.26e-05	0.000125	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—KRAS—kidney cancer	1.25e-05	0.000236	CbGpPWpGaD
Boceprevir—Vomiting—Capecitabine—kidney cancer	1.25e-05	0.000124	CcSEcCtD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.25e-05	0.000236	CbGpPWpGaD
Boceprevir—Shock—Doxorubicin—kidney cancer	1.25e-05	0.000124	CcSEcCtD
Boceprevir—Nervous system disorder—Doxorubicin—kidney cancer	1.24e-05	0.000123	CcSEcCtD
Boceprevir—Thrombocytopenia—Doxorubicin—kidney cancer	1.24e-05	0.000123	CcSEcCtD
Boceprevir—Rash—Capecitabine—kidney cancer	1.24e-05	0.000123	CcSEcCtD
Boceprevir—Dermatitis—Capecitabine—kidney cancer	1.24e-05	0.000123	CcSEcCtD
Boceprevir—Tachycardia—Doxorubicin—kidney cancer	1.24e-05	0.000123	CcSEcCtD
Boceprevir—CTSL—Immune System—JUN—kidney cancer	1.23e-05	0.000233	CbGpPWpGaD
Boceprevir—CTSV—Immune System—JUN—kidney cancer	1.23e-05	0.000233	CbGpPWpGaD
Boceprevir—Headache—Capecitabine—kidney cancer	1.23e-05	0.000122	CcSEcCtD
Boceprevir—CTSS—Immune System—KIT—kidney cancer	1.23e-05	0.000232	CbGpPWpGaD
Boceprevir—Skin disorder—Doxorubicin—kidney cancer	1.23e-05	0.000122	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—HIF1A—kidney cancer	1.23e-05	0.000232	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TSC2—kidney cancer	1.23e-05	0.000232	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CTNNB1—kidney cancer	1.23e-05	0.000231	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CTNNB1—kidney cancer	1.23e-05	0.000231	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Doxorubicin—kidney cancer	1.22e-05	0.000122	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	1.21e-05	0.000228	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL2—kidney cancer	1.2e-05	0.000227	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PIK3CA—kidney cancer	1.2e-05	0.000226	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	1.2e-05	0.000226	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MAPK3—kidney cancer	1.2e-05	0.000226	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTT1—kidney cancer	1.19e-05	0.000225	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PTEN—kidney cancer	1.19e-05	0.000225	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTEN—kidney cancer	1.19e-05	0.000225	CbGpPWpGaD
Boceprevir—Hypotension—Doxorubicin—kidney cancer	1.18e-05	0.000117	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	1.18e-05	0.000223	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KDR—kidney cancer	1.18e-05	0.000222	CbGpPWpGaD
Boceprevir—CTSK—Immune System—RAF1—kidney cancer	1.17e-05	0.000221	CbGpPWpGaD
Boceprevir—CTSK—Immune System—RELA—kidney cancer	1.17e-05	0.00022	CbGpPWpGaD
Boceprevir—Nausea—Capecitabine—kidney cancer	1.17e-05	0.000116	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—PDHB—kidney cancer	1.16e-05	0.000219	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ERBB2—kidney cancer	1.16e-05	0.000219	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—POMC—kidney cancer	1.16e-05	0.000218	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.16e-05	0.000218	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.16e-05	0.000218	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.16e-05	0.000218	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.15e-05	0.000115	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—PIK3CA—kidney cancer	1.15e-05	0.000217	CbGpPWpGaD
Boceprevir—Insomnia—Doxorubicin—kidney cancer	1.15e-05	0.000114	CcSEcCtD
Boceprevir—CTSK—Immune System—MTOR—kidney cancer	1.15e-05	0.000216	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD4—kidney cancer	1.14e-05	0.000216	CbGpPWpGaD
Boceprevir—Paraesthesia—Doxorubicin—kidney cancer	1.14e-05	0.000113	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—MAPK1—kidney cancer	1.14e-05	0.000215	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDH1—kidney cancer	1.13e-05	0.000214	CbGpPWpGaD
Boceprevir—Dyspnoea—Doxorubicin—kidney cancer	1.13e-05	0.000112	CcSEcCtD
Boceprevir—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.12e-05	0.000211	CbGpPWpGaD
Boceprevir—Dyspepsia—Doxorubicin—kidney cancer	1.12e-05	0.000111	CcSEcCtD
Boceprevir—Decreased appetite—Doxorubicin—kidney cancer	1.1e-05	0.000109	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.09e-05	0.000109	CcSEcCtD
Boceprevir—Fatigue—Doxorubicin—kidney cancer	1.09e-05	0.000108	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—CCBL1—kidney cancer	1.09e-05	0.000206	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APC—kidney cancer	1.08e-05	0.000205	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KIT—kidney cancer	1.08e-05	0.000205	CbGpPWpGaD
Boceprevir—Pain—Doxorubicin—kidney cancer	1.08e-05	0.000108	CcSEcCtD
Boceprevir—Constipation—Doxorubicin—kidney cancer	1.08e-05	0.000108	CcSEcCtD
Boceprevir—CTSK—Immune System—CDKN1B—kidney cancer	1.07e-05	0.000203	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KRAS—kidney cancer	1.07e-05	0.000203	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—kidney cancer	1.05e-05	0.000198	CbGpPWpGaD
Boceprevir—Feeling abnormal—Doxorubicin—kidney cancer	1.04e-05	0.000104	CcSEcCtD
Boceprevir—Gastrointestinal pain—Doxorubicin—kidney cancer	1.04e-05	0.000103	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—POMC—kidney cancer	1.03e-05	0.000195	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KRAS—kidney cancer	1.03e-05	0.000195	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ACY1—kidney cancer	1.03e-05	0.000194	CbGpPWpGaD
Boceprevir—CTSK—Immune System—JUN—kidney cancer	1.02e-05	0.000193	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.02e-05	0.000193	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK3—kidney cancer	1.02e-05	0.000193	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK3—kidney cancer	1.02e-05	0.000193	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—BRAF—kidney cancer	1.02e-05	0.000192	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CTNNB1—kidney cancer	1.02e-05	0.000192	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.01e-05	0.000191	CbGpPWpGaD
Boceprevir—Urticaria—Doxorubicin—kidney cancer	1.01e-05	9.99e-05	CcSEcCtD
Boceprevir—Abdominal pain—Doxorubicin—kidney cancer	1e-05	9.94e-05	CcSEcCtD
Boceprevir—Body temperature increased—Doxorubicin—kidney cancer	1e-05	9.94e-05	CcSEcCtD
Boceprevir—CTSK—Immune System—PTEN—kidney cancer	9.9e-06	0.000187	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PIK3CA—kidney cancer	9.87e-06	0.000186	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK1—kidney cancer	9.71e-06	0.000183	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK1—kidney cancer	9.71e-06	0.000183	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RAF1—kidney cancer	9.66e-06	0.000182	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RELA—kidney cancer	9.62e-06	0.000181	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ERBB2—kidney cancer	9.56e-06	0.00018	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PIK3CA—kidney cancer	9.48e-06	0.000179	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPAT—kidney cancer	9.46e-06	0.000178	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GLIPR1—kidney cancer	9.46e-06	0.000178	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MTOR—kidney cancer	9.43e-06	0.000178	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD4—kidney cancer	9.41e-06	0.000178	CbGpPWpGaD
Boceprevir—Hypersensitivity—Doxorubicin—kidney cancer	9.33e-06	9.26e-05	CcSEcCtD
Boceprevir—CTSL—Immune System—KRAS—kidney cancer	9.17e-06	0.000173	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KRAS—kidney cancer	9.17e-06	0.000173	CbGpPWpGaD
Boceprevir—Asthenia—Doxorubicin—kidney cancer	9.09e-06	9.02e-05	CcSEcCtD
Boceprevir—Pruritus—Doxorubicin—kidney cancer	8.96e-06	8.9e-05	CcSEcCtD
Boceprevir—CTSS—Immune System—CDKN1B—kidney cancer	8.85e-06	0.000167	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APRT—kidney cancer	8.8e-06	0.000166	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—FH—kidney cancer	8.8e-06	0.000166	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PDHB—kidney cancer	8.76e-06	0.000165	CbGpPWpGaD
Boceprevir—Diarrhoea—Doxorubicin—kidney cancer	8.67e-06	8.6e-05	CcSEcCtD
Boceprevir—CTSS—Immune System—IL2—kidney cancer	8.66e-06	0.000163	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RAF1—kidney cancer	8.51e-06	0.000161	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RELA—kidney cancer	8.47e-06	0.00016	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK3—kidney cancer	8.46e-06	0.00016	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	8.43e-06	0.000159	CbGpPWpGaD
Boceprevir—CTSS—Immune System—JUN—kidney cancer	8.42e-06	0.000159	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CA—kidney cancer	8.42e-06	0.000159	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CA—kidney cancer	8.42e-06	0.000159	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB2—kidney cancer	8.42e-06	0.000159	CbGpPWpGaD
Boceprevir—Dizziness—Doxorubicin—kidney cancer	8.38e-06	8.31e-05	CcSEcCtD
Boceprevir—CTSS—Immune System—CTNNB1—kidney cancer	8.36e-06	0.000158	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MTOR—kidney cancer	8.31e-06	0.000157	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTP1—kidney cancer	8.28e-06	0.000156	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPC3—kidney cancer	8.27e-06	0.000156	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CCBL1—kidney cancer	8.23e-06	0.000155	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	8.17e-06	0.000154	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—kidney cancer	8.15e-06	0.000154	CbGpPWpGaD
Boceprevir—Vomiting—Doxorubicin—kidney cancer	8.06e-06	7.99e-05	CcSEcCtD
Boceprevir—CTSK—Immune System—MAPK1—kidney cancer	8.05e-06	0.000152	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CA2—kidney cancer	8.04e-06	0.000152	CbGpPWpGaD
Boceprevir—Rash—Doxorubicin—kidney cancer	7.99e-06	7.93e-05	CcSEcCtD
Boceprevir—Dermatitis—Doxorubicin—kidney cancer	7.98e-06	7.92e-05	CcSEcCtD
Boceprevir—Headache—Doxorubicin—kidney cancer	7.94e-06	7.88e-05	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—ALAD—kidney cancer	7.84e-06	0.000148	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CDKN1B—kidney cancer	7.8e-06	0.000147	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ST3GAL2—kidney cancer	7.65e-06	0.000144	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—kidney cancer	7.63e-06	0.000144	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTM1—kidney cancer	7.61e-06	0.000144	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—kidney cancer	7.6e-06	0.000143	CbGpPWpGaD
Boceprevir—Nausea—Doxorubicin—kidney cancer	7.53e-06	7.47e-05	CcSEcCtD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	7.51e-06	0.000142	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALDH1A1—kidney cancer	7.48e-06	0.000141	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—kidney cancer	7.44e-06	0.00014	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—JUN—kidney cancer	7.42e-06	0.00014	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CTNNB1—kidney cancer	7.36e-06	0.000139	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	7.21e-06	0.000136	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—kidney cancer	7.18e-06	0.000135	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PGK1—kidney cancer	7.17e-06	0.000135	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC5A3—kidney cancer	7.17e-06	0.000135	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GLIPR1—kidney cancer	7.14e-06	0.000135	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPAT—kidney cancer	7.14e-06	0.000135	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	7.12e-06	0.000134	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LDHB—kidney cancer	7.03e-06	0.000133	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CA—kidney cancer	6.98e-06	0.000132	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK3—kidney cancer	6.96e-06	0.000131	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APRT—kidney cancer	6.64e-06	0.000125	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FH—kidney cancer	6.64e-06	0.000125	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK1—kidney cancer	6.63e-06	0.000125	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	6.62e-06	0.000125	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	6.55e-06	0.000124	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—kidney cancer	6.48e-06	0.000122	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	6.4e-06	0.000121	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ACY1—kidney cancer	6.35e-06	0.00012	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—kidney cancer	6.26e-06	0.000118	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPC3—kidney cancer	6.24e-06	0.000118	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK3—kidney cancer	6.13e-06	0.000116	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CA9—kidney cancer	6.1e-06	0.000115	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.09e-06	0.000115	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CA2—kidney cancer	6.07e-06	0.000115	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	6.07e-06	0.000114	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—kidney cancer	5.97e-06	0.000113	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALAD—kidney cancer	5.92e-06	0.000112	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.88e-06	0.000111	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK1—kidney cancer	5.84e-06	0.00011	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	5.79e-06	0.000109	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ST3GAL2—kidney cancer	5.77e-06	0.000109	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	5.77e-06	0.000109	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—kidney cancer	5.75e-06	0.000108	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	5.73e-06	0.000108	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDH1A1—kidney cancer	5.64e-06	0.000106	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	5.58e-06	0.000105	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—kidney cancer	5.51e-06	0.000104	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PGK1—kidney cancer	5.41e-06	0.000102	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A3—kidney cancer	5.41e-06	0.000102	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PDHB—kidney cancer	5.4e-06	0.000102	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—POMC—kidney cancer	5.38e-06	0.000101	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LDHB—kidney cancer	5.31e-06	0.0001	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CRABP1—kidney cancer	5.18e-06	9.78e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CCBL1—kidney cancer	5.07e-06	9.57e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—kidney cancer	5.06e-06	9.55e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.04e-06	9.52e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—kidney cancer	4.9e-06	9.24e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ITPR2—kidney cancer	4.82e-06	9.09e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	4.77e-06	9e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	4.64e-06	8.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CA9—kidney cancer	4.6e-06	8.68e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	4.54e-06	8.57e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPAT—kidney cancer	4.4e-06	8.3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.4e-06	8.3e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTT1—kidney cancer	4.39e-06	8.29e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ACHE—kidney cancer	4.39e-06	8.29e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.29e-06	8.09e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SCARB1—kidney cancer	4.16e-06	7.85e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS1—kidney cancer	4.12e-06	7.77e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FH—kidney cancer	4.09e-06	7.71e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APRT—kidney cancer	4.09e-06	7.71e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PSMD7—kidney cancer	4.04e-06	7.62e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.94e-06	7.43e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CRABP1—kidney cancer	3.91e-06	7.38e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPC3—kidney cancer	3.84e-06	7.25e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BCHE—kidney cancer	3.83e-06	7.22e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.81e-06	7.19e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC5A5—kidney cancer	3.78e-06	7.13e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CA2—kidney cancer	3.74e-06	7.06e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC2A1—kidney cancer	3.65e-06	6.89e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALAD—kidney cancer	3.64e-06	6.88e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ITPR2—kidney cancer	3.64e-06	6.86e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.56e-06	6.71e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.48e-06	6.56e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PGK1—kidney cancer	3.33e-06	6.29e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.33e-06	6.29e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTT1—kidney cancer	3.32e-06	6.26e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ACHE—kidney cancer	3.32e-06	6.26e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LDHB—kidney cancer	3.27e-06	6.17e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SCARB1—kidney cancer	3.14e-06	5.92e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS1—kidney cancer	3.11e-06	5.86e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PSMD7—kidney cancer	3.05e-06	5.75e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTP1—kidney cancer	3.05e-06	5.75e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BCHE—kidney cancer	2.89e-06	5.45e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCB1—kidney cancer	2.88e-06	5.44e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A5—kidney cancer	2.85e-06	5.38e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CA9—kidney cancer	2.83e-06	5.35e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—kidney cancer	2.8e-06	5.28e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC2A1—kidney cancer	2.76e-06	5.2e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1A1—kidney cancer	2.65e-06	5.01e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.63e-06	4.96e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CRABP1—kidney cancer	2.41e-06	4.55e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTP1—kidney cancer	2.3e-06	4.34e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ITPR2—kidney cancer	2.24e-06	4.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—kidney cancer	2.11e-06	3.98e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ACHE—kidney cancer	2.04e-06	3.85e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTT1—kidney cancer	2.04e-06	3.85e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1A1—kidney cancer	2e-06	3.78e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—POMC—kidney cancer	1.98e-06	3.73e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SCARB1—kidney cancer	1.93e-06	3.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS1—kidney cancer	1.91e-06	3.61e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PSMD7—kidney cancer	1.88e-06	3.54e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BCHE—kidney cancer	1.78e-06	3.36e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.76e-06	3.32e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.7e-06	3.2e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—kidney cancer	1.58e-06	2.98e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—POMC—kidney cancer	1.49e-06	2.82e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTP1—kidney cancer	1.42e-06	2.67e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—kidney cancer	1.38e-06	2.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCB1—kidney cancer	1.34e-06	2.53e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—kidney cancer	1.3e-06	2.46e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.23e-06	2.33e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—kidney cancer	1.19e-06	2.25e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—kidney cancer	1.04e-06	1.96e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—kidney cancer	9.71e-07	1.83e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—POMC—kidney cancer	9.2e-07	1.74e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—kidney cancer	7.34e-07	1.38e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—kidney cancer	7.33e-07	1.38e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—kidney cancer	6.4e-07	1.21e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.51e-07	8.52e-06	CbGpPWpGaD
